NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...

In a single-dose vial presentation Eli Lilly, a pharmaceutical firm has announced the launch of Mounjaro, following the authorization from the Central Drugs Standard Control Organization (CDSCO). The ...

India’s wait is over. The popular anti-obesity drug Mounjaro is finally here. The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control Organisation (CDSCO).

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling with obesity and diabetes. Priced between 3,500 and 4,375 rupees per vial, ...

Mounjaro injectable prescription medication designed to aid weight loss and manage Type 2 diabetes. It belongs to a new class of medications that act as both glucose-dependent insulinotropic ...

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

Mounjaro stands out in the pharmaceutical landscape due to its dual-action mechanism. It selectively binds to and activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...